Different doses of dual orexin receptor antagonists in primary insomnia: a Bayesian network analysis

Different doses of dual orexin receptor antagonists in primary insomnia: a Bayesian network analysis

Background: Systematic comparisons of the doses of the Food and Drug Administration (FDA)-approved dual orexin receptor antagonists (DORAs) for people with insomnia are limited.Methods: PubMed, Embase, Cochrane Library, and Clinicaltrials. gov were systematically searched to identify relevant studie...

Full description

Bibliographic Details
Main Authors: Tao Xue, Xin Wu, Jiaxuan Li, Shujun Chen, Zilan Wang, Xin Tan, Zhong Wang, Jianguo Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-05-01
Series:Frontiers in Pharmacology
Subjects:
suvorexant
lemborexant
daridorexant
network meta-analysis
DORA
dual orexin receptor antagonist
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2023.1175372/full

Similar Items

Similar Items